Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
especially Products
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
 

Gatimin ® Taj Products

 
HOME >> PRODUCTS >> Taj Products >> Gatimin
Taj  ALL Products View Products According to Category
 

Each tablet contains:

 

Composition:

Gatifloxacin......................................................................400 mg

 

Indications:

Gatifloxacin is indicated for the treatment of infections due to susceptible strains of the designated micro-organisms in the conditions listed below:

Acute bacterial exacerbation of chronic bronchitis due to Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, or Staphylococcus aureus. Acute sinusitis due to Streptococcus pneumoniae or Haemophilus influenzae.Community acquired pneumoniae due to Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus, Mycoplasma pneumoniae, Chlamydia pneumoniae or Legionella pneumophila. Uncomplicated urinary tract infections (cystitis) due to E.coli, Klebsiella pneumoniae or Proteus mirabilis. Complicated urinary tract infections due to E.coli, Klebsiella pneumoniae or Proteus mirabilis.Pyelonephritis due to E.coli Uncomplicated urethral and cervical gonorrhea due to Neisseria gonorrhoeae. Acute, uncomplicated rectal infections in women due to Neisseria gonorrhoeae.

 

 Description:

Gatifloxacin, a new type of quinolone antibiotic, has been approved by the U.S. Food and Drug      Administration for indications including the treatment of community-acquired respiratory tract infections (RTIs). It was designed with a unique 8-methoxy structure that appears to enhance bactericidal action and decrease the rate of the development of resistance of gram-positive bacteria.

 

Dosage and Administration:

The recommended dosage for gatifloxacin tablets is described below.

Doses of Gatimin are administered once every 24 hours.

Acute Bacterial Exacerbation of Chronic Bronchitis

400 mg once daily for 7-10 days

Acute Sinusitis

400 mg once daily for 10 days

Community acquired pneumonia

400 mg once daily for 7-14 days

Uncomplicated urinary tract infections (Cystitis)

400 mg stat dose once daily for 3 days

Acute pyelonephritis

400 mg once daily for 7-10 days

 Gonorrhea in women.

400 mg as a single dose

 

Contraindications:

Gatimin is contraindicated in persons with a history of hypersensitivity to gatifloxacin or any member of the quinolone class of antimicrobial agents.


Dosage: Dosages of Gatimin are administered once every 24 hours.

 

 Presentations:    10 tablets

 


Note : This product information is intended only for residents of the India. Taj Pharmaceuticals Limited,  medicines help to treat and prevent a range of conditions—from the most common to the most challenging—for people around the world.

Information for Health Care Professionals

*** Please consult local Prescribing Information for any product before use. This website is an international information resource for healthcare professionals with an interest in disease management. This website is not intended to replace the advice of a qualified healthcare professional. Above brand is a trademark of the Taj group of companies (Taj Pharmaceuticals Limited).

 

 


 



Gatimin

 

 

 

 

 

 

 

 

 

 

 


 

 

              
 Print page   Send by mail
 

   
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM

 

 

 

 
 www.tajpharma.com

   

 

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement